X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

DoKaSch Temperature Solutions appoints Sales & Business Development Manager for China

Content Team by Content Team
3rd June 2023
in News
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

DoKaSch Temperature Solutions is strengthening its foothold in Asia. The provider of temperature-controlled packaging solutions has appointed Emily Tang as Sales & Business Development Manager for China. Based in China, Tang has been catering to the needs of customers using the Opticooler® packaging solution since this year. This active temperature-controlled air freight container features an extremely high level of safety and reliability.

The new position was created specifically to further strengthen DoKaSch TS’s global presence in one of the most important Asian-Pacific regions for the pharma and biotech industry. Based in Guangdong in southern China, Tang is also well-positioned to serve eastern China and Shanghai in particular, where most producers of pharmaceuticals, biotech materials, and active pharmaceutical ingredients (APIs) are located.

The appointment of Tang adds an experienced international sales agent with extensive knowledge of cold chain logistics in the APAC region to DoKaSch TS. Her previous positions first took the graduate of a Master’s degree in Logistics Management to World Courier. She was responsible for business in South and Southwest China at this global cold chain logistics company. The sales professional then worked for Catalent Solutions. There, Tang gained valuable experience with clinical trial supplies for multiple countries and was part of the APAC team responsible for business development in Southern and Southwestern China, Hong Kong, and Taiwan.

“The APAC-Region and especially China is a strong growth market for pharmaceutical manufacturing. We are seeing a sharp increase in clinical trials, as multinational companies and local pharmaceutical producers have started to engage in more and more of these trials in multiple countries here. DoKaSch Temperature Solutions’ Opticooler® will play an important role in supporting the rise of the Chinese and Asian-Pacific pharma industry by providing reliable cold chains for biologics, vaccines, and APIs. As an active temperature-controlled packaging solution with a strong and global service network, customers can enjoy an extremely high degree of safeguarding against temperature excursion paired with outstanding availability,” says Emily Tang, Sales & Business Development Manager China at DoKaSch Temperature Solutions.

Andreas Seitz, Managing Director of DoKaSch Temperature Solutions, also sees that the region offers huge potential. “By bringing Emily on board, we are gaining an experienced international business development professional who is well-versed in the cold chain business in China and the APAC region. After the establishment of our service stations in Beijing, Tokyo and the Indian city of Hyderabad, the appointment of our Sales & Business Development Manager in China is another important step in the execution of our Asia strategy.”

Previous Post

Adapting To The Changing Virus By Enhancing Vaccine Immunity

Next Post

Advancing RNA Therapeutics With UK Drug Delivery Centre

Related Posts

Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Next Post

Advancing RNA Therapeutics With UK Drug Delivery Centre

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In